SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-050545
Filing Date
2022-09-19
Accepted
2022-09-19 17:06:11
Documents
2
Period of Report
2022-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1556
2 EX-24 DOCUMENT attachment1.htm EX-24 4249
  Complete submission text file 0001209191-22-050545.txt   7246
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Issuer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RUBIUS THERAPEUTICS 325 VASSAR ST., STE. 1A CAMBRIDGE MA 02139
Business Address
OH ANDREW M. (Reporting) CIK: 0001746614 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37813 | Film No.: 221251237